Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $54.48 +1.70%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Kroger meets earnings expectations, revenue tops estimates
- CarMax (KMX) Tops Q1 EPS by 35c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
